Vanguard Group’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.44K | Hold |
|
|||||
|
2023
Q4 | $2.8K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $20.8K | Sell |
|
|||||
|
2022
Q3 | $65K | Hold |
|
|||||
|
2022
Q2 | $148K | Hold |
|
|||||
|
2022
Q1 | $175K | Hold |
|
|||||
|
2021
Q4 | $223K | Buy |
|
|||||
|
2021
Q3 | $312K | Hold |
|
|||||
|
2021
Q2 | $326K | Buy |
|
|||||
|
2021
Q1 | $376K | Buy |
|
|||||
|
2020
Q4 | $112K | Buy |
|
|||||
|
2020
Q3 | $111K | Buy |
|
|||||
|
2020
Q2 | $138K | Buy |
|
|||||
|
2020
Q1 | $42K | Buy |
|
|||||
|
2019
Q4 | $20K | Hold |
|
|||||
|
2019
Q3 | $19K | Buy |
|
|||||
|
2019
Q2 | $51K | Sell |
|
|||||
|
2019
Q1 | $39K | Buy |
|
|||||
|
2018
Q4 | $23K | Buy |
|
|||||
|
2018
Q3 | $51K | Hold |
|
|||||
|
2018
Q2 | $67K | Sell |
|
|||||
|
2018
Q1 | $98K | Buy |
|
|||||
|
2017
Q4 | $59K | Sell |
|
|||||
|
2017
Q3 | $134K | Buy |
|
|||||
|
2017
Q2 | $102K | Hold |
|
|||||
|
2017
Q1 | $98K | Hold |
|
|||||
|
2016
Q4 | $88K | Hold |
|
|||||
|
2016
Q3 | $110K | Buy |
|
|||||
|
2016
Q2 | $45K | Hold |
|
|||||
|
2016
Q1 | $38K | Sell |
|
|||||
|
2015
Q4 | $79K | Hold |
|
|||||
|
2015
Q3 | $273K | Hold |
|
|||||
|
2015
Q2 | $610K | Buy |
|
|||||
|
2015
Q1 | $585K | Hold |
|
|||||
|
2014
Q4 | $531K | Buy |
|
|||||
|
2014
Q3 | $705K | Buy |
|
|||||
|
2014
Q2 | $624K | Buy |
|
|||||
|
2014
Q1 | $869K | Buy |
|
|||||
|
2013
Q4 | $883K | Buy |
|
|||||
|
2013
Q3 | $765K | Buy |
|
|||||
|
2013
Q2 | $473K | Buy |
|